Pediatrix Medical MD
$30.22 +$0.28 (+0.94%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $30.22 0.00%
Open$29.96
Prev close$29.94
Day range$29.89 – $30.43
Volume791.0K
Market cap$2.36B
P/E (TTM)16.5
Dividend yield–
Earnings
Average move on report day±10.9%last 16 reports
Closed higher10 of 1663% of the time
Best reaction+24.2%
Worst reaction-12.2%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 29 Oct 2026 | Pre Market | ±13.3% | +0.93% | Within range |
| 2026/Q2 | 4 Aug 2026 | Pre Market | ±15.8% | -5.87% | Within range |
| 2026/Q1 | 5 May 2026 | Pre Market | ±12.6% | -7.05% | Within range |
| 2025/Q4 | 19 Feb 2026 | Pre Market | ±10.2% | -12.15% | Bigger than priced |
| 2025/Q3 | 3 Nov 2025 | Pre Market | ±14.9% | +24.22% | Bigger than priced |
| 2025/Q2 | 5 Aug 2025 | Pre Market | ±22.4% | +5.04% | Within range |
| 2025/Q1 | 6 May 2025 | Pre Market | ±18.6% | +11.81% | Within range |
| 2024/Q4 | 20 Feb 2025 | Pre Market | ±14.9% | +22.11% | Bigger than priced |
| 2024/Q3 | 1 Nov 2024 | Pre Market | ±15.7% | +23.46% | Bigger than priced |
| 2024/Q2 | 6 Aug 2024 | Pre Market | ±3.5% | +17.72% | Bigger than priced |
| 2024/Q1 | 7 May 2024 | Pre Market | ±15.2% | -2.48% | Within range |
| 2023/Q4 | 20 Feb 2024 | Pre Market | ±17.7% | -8.93% | Within range |
| 2023/Q3 | 2 Nov 2023 | Pre Market | ±10.5% | -11.78% | Bigger than priced |
| 2023/Q2 | 3 Aug 2023 | Pre Market | ±18.5% | +6.66% | Within range |
| 2023/Q1 | 2 May 2023 | Pre Market | ±11.2% | +2.86% | Within range |
| 2022/Q4 | 17 Feb 2023 | Pre Market | ±16.6% | +10.88% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$501.37M+1.7% YoY
Operating profit$71.33M-3.6% YoY
Net profit$46.99M-34.5% YoY
Diluted EPS$0.59-29.8% YoY
Free cash flow$112.93M-14.4% YoY
Operating cash flow$117.31M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin26.1%
Operating margin12.1%
Net margin7.7%
Return on equity17.2%
Return on assets6.9%
Return on invested capital11.7%
Current ratio1.28
Liabilities / assets60.3%
Cash & investments$425.84M
Total debt$600.98M
Net cash (debt)-$175.14M
Free cash flow / sales10.7%
No comments yet — be the first to weigh in on MD.
Sign in to join the discussion.